Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective.

Osnabrugge RL, Magnuson EA, Serruys PW, Campos CM, Wang K, van Klaveren D, Farooq V, Abdallah MS, Li H, Vilain KA, Steyerberg EW, Morice MC, Dawkins KD, Mohr FW, Kappetein AP, Cohen DJ; SYNTAX trial investigators.

Heart. 2015 Dec;101(24):1980-8. doi: 10.1136/heartjnl-2015-307578. Epub 2015 Nov 9.

PMID:
26552756
2.

Differences in baseline characteristics, practice patterns and clinical outcomes in contemporary coronary artery bypass grafting in the United States and Europe: insights from the SYNTAX randomized trial and registry.

Head SJ, Parasca CA, Mack MJ, Mohr FW, Morice MC, Holmes DR Jr, Feldman TE, Dawkins KD, Colombo A, Serruys PW, Kappetein AP; SYNTAX Investigators.

Eur J Cardiothorac Surg. 2015 Apr;47(4):685-95. doi: 10.1093/ejcts/ezu197. Epub 2014 May 12.

PMID:
24819358
3.

Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.

Mohr FW, Morice MC, Kappetein AP, Feldman TE, Ståhle E, Colombo A, Mack MJ, Holmes DR Jr, Morel MA, Van Dyck N, Houle VM, Dawkins KD, Serruys PW.

Lancet. 2013 Feb 23;381(9867):629-38. doi: 10.1016/S0140-6736(13)60141-5.

PMID:
23439102
4.

The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.

Kapur A, Bartolini D, Finlay MC, Qureshi AC, Flather M, Strange JW, Hall RJ.

J Cardiovasc Med (Hagerstown). 2010 Jan;11(1):26-33. doi: 10.2459/JCM.0b013e328330ea32.

PMID:
19797974

Supplemental Content

Loading ...
Support Center